Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Febuxostat on Coronary Plaque Volume in Angina
NCT02279342Phase 4Terminated
- Sponsor
- Yokohama City University Medical Center
- Start
- Oct 2014
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of febuxostat in coronary artery disease (CAD), hyperuricemia, sponsored by Yokohama City University Medical Center. Started Oct 2014; status: terminated.
02
Drugs
febuxostat
03
Conditions
coronary artery disease (CAD)hyperuricemia
Beyond the preview
Go deeper on NCT02279342.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02279342.